Rebecca E. Scully

Rebecca Scully practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Rebecca Scully's NPI, 1104260900, was assigned on April 23, 2013. Rebecca Scully graduated from Geisel School of Medicine at Dartmouth in 2013. Rebecca Scully holds New Hampshire license 2086S0129X.

Rebecca Scully's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Rebecca Scully's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Rebecca Scully is also affiliated with Alice Peck Day Memorial Hospital. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Rebecca Scully to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rebecca Scully practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Rebecca Scully's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Rebecca Scully is licensed in New Hampshire.

CMS data shows 720 Medicare services from Rebecca Scully across 14 procedure codes in 2024, for 646 Medicare patients. Medicare paid $22,592 for them.

CMS counts 646 Medicare patients who saw Rebecca Scully in 2024. The largest group is 65 to 74, with 251 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rebecca Scully's median patient age at 67, with 48% women.

In 2024, Rebecca Scully wrote 131 Medicare Part D claims for 50 patients. 68% of them were for generic drugs. CMS names the drug for 104 of them, across 4 drugs with 11 or more claims each, at $33,640 in total drug cost. In 2023, CMS named 79 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Rebecca Scully for performance year 2024, reported through an alternative payment model (APM). Rebecca Scully accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rebecca Scully as offering telehealth. CMS counts 13 procedures of leg revascularization (restoring blood flow) by Rebecca Scully, more than 68% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 29 general payments to Rebecca Scully from 8 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 65% of the total. Medtronic, Inc. paid the most, $1,216.

Rebecca Scully graduated from Geisel School of Medicine at Dartmouth in 2013.